ABSTRACT

In still another procedure, supercritical fluids can be uniquely used to encapsulate very hydrophobic molecules such as potent anticancer drugs, for example, paclitaxel, camptothecin, (a very effective topoisomerase-I inhibitor), and other anti-infective (antiHIV) agents [49]. In this case, the hydrophobic drug and the phospholipids are directly solubilized in the supercritical fluids prior to their injection into a phosphate buffered saline (PBS) or some other biocompatible solvents. After decompression through a nozzle, the supercritical fluids evaporate leaving an aqueous dispersion of liposomes containing hydrophobic molecules entrapped within their lipid bilayer.